Skip to main content
. 2023 Apr 17;29(9):2690–2704. doi: 10.1111/cns.14213

FIGURE 5.

FIGURE 5

PTX3 upregulation promoted the malignant phenotype of t‐DCs. (A, B) The transfection efficiency was verified by qRT‐PCR and western blot. (C) CCK8 assay on t‐DCs with PTX3 upregulation. (D) Clone formation assay on t‐DCs with PTX3 upregulation. (E, F) Transwell and wound healing assay of t‐DCs with PTX3 upregulation. (G) Tumorigenicity assay performed in nude mice by subcutaneous inoculation of t‐DCs with PTX3 upregulation. Data are expressed as mean ± SD, *p < 0.05, **p < 0.01, ***p < 0.001.